| IV-33 Denise Morris Population Pharmacokinetic Modeling of Fremanezumab in Support of Phase 3 Development for Patients with Migraine Thursday 15:10-16:40 |
| IV-33 Denise Morris Population Pharmacokinetic Modeling of Fremanezumab in Support of Phase 3 Development for Patients with Migraine Thursday 15:10-16:40 |